Fingerprint
Dive into the research topics of 'CBP/Β-catenin/FOXM1 is a novel therapeutic target in triple negative breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
CBP/Β-catenin/FOXM1 is a novel therapeutic target in triple negative breast cancer
Alexander Ring, Cu Nguyen, Goar Smbatyan, Debu Tripathy, Min Yu, Michael Press, Michael Kahn, Julie E. Lang
Research output: Contribution to journal › Article › peer-review
35
Scopus
citations